Nkure Therapeutics Private Limited, a active private limited company, was established on 11 February 2022 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U73100KA2022PTC157838. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹2.70 Cr.
It upholds a compliant status. Its leadership includes Ashok Nana Vohra (Director), Mahendra Surendra Rao (Director), Lalitkumar Manjunath Pai (Director). Past directors included Mahendra Surendra Rao, Lalitkumar Manjunath Pai, Alka Vohra. Its latest AGM occurred on 18 August 2025, with the balance sheet filed on 31 March 2025. It is based at Desk No. 15-L, No. 14, Bhattarahalli, Old Madras Road, Kr Puram,, Bangalore, Karnataka, 560049.
U73100KA2022PTC157838
157838
11 February 2022
₹4.50 Cr
₹2.70 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Nkure Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashok Nana Vohra | Director | 11 Feb 2022 | Current |
| Mahendra Surendra Rao | Director | 04 Mar 2022 | Current |
| Lalitkumar Manjunath Pai | Director | 01 Aug 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 04 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nkure Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Nkure Therapeutics had a public holding of 84.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Nkure Therapeutics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nkure Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nkure Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nkure Therapeutics Private Limited last Annual general meeting of members was held on 18 Aug 2025 as per latest MCA records. was recorded as a recent event.
Progress on Nkure Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
The activity Lalitkumar Manjunath Pai was appointed as a Director was appointed as a Director on 01 Aug 2023 & has been associated with this company since 2 years 5 months . was completed.
Mahendra Surendra Rao was appointed as a Director was appointed as a Director on 04 Mar 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
Progress on Ashok Nana Vohra was appointed as a Director was appointed as a Director on 11 Feb 2022 & has been associated with this company since 3 years 11 months . was documented.
Nkure Therapeutics Private Limited was registered on 11 Feb 2022 with Roc Bangalore & aged 3 years 11 months as per MCA records. was recorded as a recent event.
The CIN of Nkure Therapeutics Private Limited is U73100KA2022PTC157838.
Nkure Therapeutics Private Limited is headquartered at Desk No. 15-L, No. 14, Bhattarahalli, Old Madras Road, Kr Puram,, Bangalore, Karnataka, 560049.
Nkure Therapeutics Private Limited was incorporated on 11 February 2022.
The current directors of Nkure Therapeutics Private Limited are
The primary industry of Nkure Therapeutics Private Limited is Professional, Scientific And Technical.
Nkure Therapeutics Private Limited is unlisted.
The authorized capital of Nkure Therapeutics Private Limited is ₹4.50 Cr, and the paid-up capital is ₹2.70 Cr.
The compliance status of Nkure Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX